Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis

April W. Armstrong, Ahmed Ameen, Silvia Ferrucci, José-Juan Pereyra-Rodríguez, Michael J. Cork, Cory Rubin, Abel Jarell, Alessandra Narcisi, Pierre-Andre Becherel, Jennifer Beecker, Teodora Festini, Ida Vittrup, Frank Vinther, Diamant Thaçi

Open source

DOI
10.1007/s13555-026-01869-w
Published
2026-08-20
Container
Dermatology and Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01869-w,
  title = {Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis},
  author = {April W. Armstrong and Ahmed Ameen and Silvia Ferrucci and José-Juan Pereyra-Rodríguez and Michael J. Cork and Cory Rubin and Abel Jarell and Alessandra Narcisi and Pierre-Andre Becherel and Jennifer Beecker and Teodora Festini and Ida Vittrup and Frank Vinther and Diamant Thaçi},
  year = {2026},
  journal = {Dermatology and Therapy},
  doi = {10.1007/s13555-026-01869-w},
  url = {https://doi.org/10.1007/s13555-026-01869-w}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis
AU  - April W. Armstrong
AU  - Ahmed Ameen
AU  - Silvia Ferrucci
AU  - José-Juan Pereyra-Rodríguez
AU  - Michael J. Cork
AU  - Cory Rubin
AU  - Abel Jarell
AU  - Alessandra Narcisi
AU  - Pierre-Andre Becherel
AU  - Jennifer Beecker
AU  - Teodora Festini
AU  - Ida Vittrup
AU  - Frank Vinther
AU  - Diamant Thaçi
PY  - 2026
JO  - Dermatology and Therapy
DO  - 10.1007/s13555-026-01869-w
UR  - https://doi.org/10.1007/s13555-026-01869-w
ER  - 

APA

Armstrong, A. W., Ameen, A., Ferrucci, S., Pereyra-Rodríguez, J., Cork, M. J., Rubin, C., Jarell, A., Narcisi, A., Becherel, P., Beecker, J., Festini, T., Vittrup, I., Vinther, F., & Thaçi, D. (2026). Real-World Effectiveness and Safety of 12 Months of Tralokinumab in Patients with Atopic Dermatitis. Dermatology and Therapy. https://doi.org/10.1007/s13555-026-01869-w

Source records